Xenoscience, Inc.

Phoenix, Arizona 85013

1 studies enrolling now · 30 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease, Alzheimer's Disease Dementia, Cerebral Cavernous Malformation, Dopamine Beta Hydroxylase Deficiency, Drug Resistant Partial Onset Seizure, Early Alzheimer's Disease, Epilepsy With Simple or Complex Partial Onset Seizures, Focal Epilepsy, Irritation/Irritant, Migraine, Migraine, With or Without Aura

Studies at this site

A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease — Running, not enrolling
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine — Running, not enrolling
Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy — Running, not enrolling
A Study to Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age — Running, not enrolling
Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects — Stopped early
The Symptomatic Cerebral Cavernous Malformation Trial of REC-994 — Completed
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab — Running, not enrolling
Long-term Safety and Tolerability of BHV-7000 — Enrolling by invitation
Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease — Completed
Open-label Extension for Phase 3 Clinical Trials of Simufilam — Stopped early
A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease — Stopped early
A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention — Stopped early
A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy — Running, not enrolling
Study of BHV-4157 in Alzheimer's Disease — Completed
GAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's Disease — Completed
Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension — Completed
Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease — Stopped early
Study in Elderly Alzheimer's Patients to Assess Skin Tolerability, Irritation With 3, 7-Day Applications of DTP-System — Completed
221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease — Stopped early
Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations — Stopped early
An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine — Completed
Efficacy, Safety, and Tolerability Study of Oral Ubrogepant in the Acute Treatment of Migraine — Completed
Evaluation of the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes — Stopped early
A Cross-Over, Multi-Center Trial to Evaluate the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes — Withdrawn before enrolling
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs — Completed
Study of Combination Therapy With Dimebon and Donepezil (Aricept) in Patients With Alzheimer's Disease — Stopped early
To Evaluate The Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures — Completed
Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) — Completed
Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) — Completed
Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing Off — Stopped early